Biohope receives phase 2 EU funds in the “SME instrument” of the H2020 program.

Biohope is delighted to announce the funding concession from European Comission of a phase 2 grant SME intrument – Horizon 2020.
 234639-EU_commission
The companies involved in the projects will also benefit from 12 days of business coaching. Biohope faces the clinical development of its products with the support of the European Commission.
In the coming years, this highly valued EU funding support will enable to face the technological and clinical challenges of potential diagnostic tools and personalized therapy development in the field of renal transplantation.
2016-10-18T12:55:49+00:00June 29th, 2016|Research|Comments Off on Biohope receives phase 2 EU funds in the “SME instrument” of the H2020 program.